TAO Synergies TAOX
NASDAQ TAOX
$4.14 +0.13 (+3.24%)
As of: Sep 9, 2026 · 11:58 AM EDT

TAO Synergies (TAOX) Cash from Operations (2019 - 2026)

TAO Synergies' (TAOX) quarterly Cash from Operations came in at -$874981.0 in Q2 2026, down 16.81% on a YoY basis from -$1.1 million in Q2 2025, and up 48.01% quarter-over-quarter from -$1.7 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Cash from Operations (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Cash from Operations for 8 consecutive years, with -$874981.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Operations fell 16.81% year-over-year to -$874981.0; the trailing twelve-month figure through Jun 2026 stood at -$6.2 million (down 25.35% YoY), and the FY2025 full-year result was -$6.4 million, down 30.94% from the prior year.
  • Cash from Operations advanced to -$874981.0 in Q2 2026 per TAOX's latest filing, from -$1.7 million in the prior quarter.
  • Across five years, Cash from Operations topped out at -$749072.0 in Q2 2025 and bottomed at -$3.5 million in Q1 2022.
  • Historically, Cash from Operations has averaged -$1.7 million across 5 years, with a median of -$1.5 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Cash from Operations tumbled 123.86% in 2022, then surged 61.7% in 2023.
  • Over 5 years, Cash from Operations stood at -$2.8 million in 2022, then soared by 61.7% to -$1.1 million in 2023, then retreated by 9.56% to -$1.2 million in 2024, then tumbled by 109.85% to -$2.5 million in 2025, then jumped by 64.3% to -$874981.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered -$874981.0, -$1.7 million, and -$2.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Amgen 211.88 Bn 197.89 Bn 7.24 Bn 4.00 Bn
2 Gilead Sciences 181.55 Bn 178.37 Bn 6.22 Bn 3.57 Bn
3 Vertex Pharmaceuticals 132.31 Bn 124.45 Bn 2.84 Bn 1.13 Bn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn 813.00 Mn
5 Argenx Se 61.54 Bn 56.36 Bn 1.37 Bn -
6 Moderna 54.69 Bn 49.55 Bn 52.00 Mn -526.00 Mn
7 Alnylam Pharmaceuticals 34.07 Bn 30.76 Bn 992.69 Mn 326.72 Mn
8 Biogen 31.41 Bn 30.12 Bn 1.96 Bn 448.90 Mn
9 Roivant Sciences 30.10 Bn 30.10 Bn 1.16 Mn -270.50 Mn
10 TAO Synergies 30.93 Mn 30.93 Mn - -874,981.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -874,981.00
Mar 31, 2026 -1.68 Mn
Dec 31, 2025 -2.45 Mn
Sep 30, 2025 -1.19 Mn
Jun 30, 2025 -749,072.00
Mar 31, 2025 -2.00 Mn
Dec 31, 2024 -1.17 Mn
Sep 30, 2024 -1.03 Mn
Jun 30, 2024 -853,534.00
Mar 31, 2024 -1.83 Mn
Dec 31, 2023 -1.07 Mn
Sep 30, 2023 -1.17 Mn
Jun 30, 2023 -1.24 Mn
Mar 31, 2023 -1.70 Mn
Dec 31, 2022 -2.78 Mn
Sep 30, 2022 -2.42 Mn
Jun 30, 2022 -2.52 Mn
Mar 31, 2022 -3.49 Mn
Dec 31, 2021 -2.05 Mn
Sep 30, 2021 -1.08 Mn